Zacks Investment Research on MSN
Axsome Therapeutics begins Phase III study on AXS-14 for fibromyalgia
Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines recommended for children in the US have not been tested against placebos, ...
In picking Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services, President-elect Donald Trump is elevating a small but growing segment of the population that distrusts ...
GlobalData on MSN
BMS reports positive results in Phase III SCOUT-HCM trial for oHCM
The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.
Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.
The Trump administration plans to impose a new testing requirement for new vaccines — a demand that could delay the availability of the next round of COVID-19 vaccines and complicate the approval of ...
This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. The Trump administration plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback